Advertisement

Cardiff scientists discover cancer-fighting compound

Credit: Britta Pedersen/DPA/PA Images

Cardiff University says scientists have developed a new anti-cancer stem cell agent capable of targeting aggressive tumour forming cells common to breast, pancreas, colon and prostate cancers.

The new OH14 compound has been licensed by Tiziana Life Sciences, a British-based pharmaceutical company.

It will now undergo further development before undergoing clinical trials. Researchers say studies have shown it to be effective in eliminating a number of different kinds of cancers cells, including cancer stem cells from breast cancer patients.

The breakthrough comes almost exactly a year after the same research team announced that they had discovered a molecule capable of reversing the spread of malignant breast cancer.

Our computer aided drug screening process has now identified two new classes of anti-cancer agents, specifically targeting two distinct and novel mechanisms underpinning cancer.

РDr Andrea Brancale, Cardiff University’s School of Pharmacy